Hokyoung Yu is the Chief Financial Officer at SD BIOSENSOR, leveraging a strong background in finance from his time as a Director at NH Investment & Securities and an accountant at Deloitte. He previously served as the companys Head of Strategic Planning and holds a Bachelors degree from Yonsei University.
There is no publicly available information regarding Hokyoung Yus personal life, hobbies, or interests outside of his professional career.
He played an instrumental role in SD BIOSENSORs $1. 53 billion acquisition of U. S. diagnostics firm Meridian Bioscience, a major strategic expansion into the North American market.
Hokyoung Yu
Chief Financial Officer at SD BIOSENSOR INC
South Korea
Overview
Topics They Care About
Healthcare M&A
Was a key figure in the successful acquisition of Meridian Bioscience for $1. 53 billion, significantly expanding the company's global footprint and capabilities.
Corporate Finance
His career progression from Deloitte and NH Investment & Securities to CFO demonstrates extensive expertise in financial strategy, investment, and corporate financial management.
In Vitro Diagnostics (IVD)
As a key executive at SD BIOSENSOR, a global IVD leader, he is deeply involved in the financial and strategic direction of the diagnostics market.
Media Appearances
Hokyoung has no verified media appearances
Work History
4-2023
Chief Financial Officer at SD BIOSENSOR INC
10-2021 - 3-2023
전략기획실장 at SD BIOSENSOR INC
5-2010 - 9-2021
Director at NH Investment & Securities
3-2007 - 5-2010
financial team leader at Woongjin, INC.
9-2000 - 3-2007
Accountant at Deloitte (Accounting Firm)
Education
1995 - 2000
Bachelor's degree from Yonsei University
More Information
Social Presence :
Prographics :
Exp : 25
Location : South Korea
Job Level : Leadership
Designation : Chief Financial Officer at SD BIOSENSOR INC
